Lighting the Way to a Cure

  • Financials
  • Patient Library
  • Blog
  • Calendar
FSHD Header Logo
mobile-logo

  • Who We Are
        • About Us
          • History
          • Mission
          • Our Team
        • Our Impact
          • Therapeutic Accelerator
          • Education
          • Advocacy
          • Our Partners
        • Journey To A Cure
          • 2022 Donor Impact Report
  • Understanding FSHD
        • What is FSHD
          • Symptoms
          • Diagnosis
          • Early-onset FSHD
          • Genetic Testing
        • Living with FSHD
          • Newly Diagnosed?
          • Finding Care
          • Symptom Management
          • Patient Library
        • FSHD University
          • Physical Health
          • Wellness
          • Research
  • Get Involved
        • Support Us
          • Ways to Give
          • Become a Torchbearer
          • Raise Awareness
          • Volunteer
          • Fundraise
        • Advance Research
          • Patient Involvement
          • True Cost of FSHD Study
          • Clinical Trials
          • Donate tissue
        • Connect
          • Find Your Local Chapter
          • Join the Community
          • World FSHD Alliance
          • Online Communities
        • Events
          • Walk & Roll to Cure FSHD
          • Events Calendar
          • FSHD 360 Regional Conferences
          • FSHD Connect Conference
  • Research
        • For Patients & Families
          • Advance Research
          • True Cost of FSHD Study
          • TestFSHD genetic testing
          • Clinical Trials
        • For Researchers
          • Apply for a Grant
          • Research We Have Funded
          • Resources
          • Int’l Research Congress
        • For Clinicians
          • FSHD Masterclass
          • ICD-10
        • Global Collaboration
          • Therapeutic Accelerator
          • Clinical Trial Research Network
          • Drug Development Pipeline
          • Project Mercury
  • News
    • Media Library
    • Blog
      • Living with FSHD
        • Health and Medicine
        • PT and Exercise
        • Tips and Tricks
        • Mental Health
      • FSHD Society News
      • FSHD Research
      • Fundraising & Events
      • Media & PR
    • FSHD Society Radio
    • The FSHD Advocate
  • JOIN US
  • Donate
  • JOIN US
  • Donate

Advocacy

Home / Our Impact / Advocacy

A major focus of the Society’s advocacy work has been to push for greater U.S. government support for FSHD research. Our efforts have included:

  • Testifying before Congressional committees with jurisdiction to appropriate funds for biomedical research.
  • Studying pending legislation.
  • Meeting with officials of the National Institutes of Health (NIH) institutes with responsibility for the muscular dystrophies.
  • Organizing, sponsoring, and attending conferences and symposia.
  • Informing other forums such as the National Academy of Sciences and the Institute of Medicine about increasing the level of support for FSHD research.
  • Participating in the MDStarNet muscular dystrophy public surveillance research on aspects of FSHD issues.
  • Engaging the Food and Drug Administration through our Voice of the Patient Report.
Advocacy in DC

The Society also continually educates Congress on behalf of all concerned with FSHD. Each year, the Society submits written and oral Congressional testimonies on the status of funding and progress on building FSHD research portfolios as well as on the current scientific opportunities in FSHD basic, translational, and clinical research. The Society also submits appropriations testimony before the U.S. House and U.S. Senate Appropriations committees regarding appropriations for the NIH for research on FSHD.

Other advocacy efforts

  • Accumulating, disseminating, and encouraging the exchange of information about FSHD, including educating the general public, governmental bodies, and the medical and scientific professions about FSHD. Our Patient Engagement Toolkit informs health care providers about the importance of engaging their FSHD patients in chapter activities, clinical research, and clinical trials;
  • Acting as a liaison among consumers, government, and industry concerning research and development of drugs, therapies, and devices for FSHD.
  • World FSHD Alliance, an informal federation of FSHD patient advocacy organizations around the world aligned around a unified strategy to educate, empower, and engage patients while advocating for clinical and research infrastructure to improve medical care and accelerate therapy development.

Our efforts have been met with success as the FSHD Society has achieved unprecedented visibility and attention for FSHD. Here are some examples of our advocacy milestones over the past decade:

MD-CARE Act 2001. The FSHD Society was instrumental in rewriting the MD CARE ACT 2001 to meet the needs of the entire community—people with all nine major types of muscular dystrophy. On December 18, 2001, Congress passed the Muscular Dystrophy Community Assistance Research and Education Act (MD CARE ACT), a law mandating research, study, and education on each type of muscular dystrophy. The law established the Muscular Dystrophy Coordinating Committee (MDCC) oversight committee to coordinate activities across the NIH, national research institutes, and federal health programs relating to all forms of muscular dystrophy. The MDCC is responsible for developing and implementing a plan for conducting and supporting research and education on muscular dystrophy, measuring progress, and periodically reviewing and revising the plan.

MD-CARE Act 2008. The FSHD Society was also quite involved with the MD CARE ACT 2008 reauthorization process and made suggestions and comments to strengthen the Act for all non-Duchenne muscular dystrophies.

MD-CARE Act 2014 Re-authorization. The FSHD Society provided extensive commentary and status updates to the MDCC on progress in FSHD research and patient care, as well as recommendations of priority areas for the future.

MD Coordinating Committee Testimony
  • 2018 FSH Society MDCC presentation
  • 2016 FSH Society MDCC presentation
  • 2015 FSH Society MDCC presentation
  • 2014 FSH Society MDCC presentation
Congressional Testimony
  • FY 2023 written testimony before the US House Appropriations Committee, Subcommittee on Labor, Health and Human Services, Education and Related Agencies requesting $25 million FY2023 appropriations for NIH research on FSHD (PDF)
  • FY2023 written testimony before U.S. Senate Appropriations Subcommittee on Labor, HHS, Education and Related Agencies (PDF)
  • FY2022 written testimony before U.S. Senate Appropriations Subcommittee on Labor, HHS, Education and Related Agencies (PDF)
  • FY 2022 written testimony before the US House Appropriations Committee, Subcommittee on Labor, Health and Human Services, Education and Related Agencies requesting $28 million FY2022 appropriations for NIH research on FSHD (PDF)
  • FY2021 written testimony before U.S. Senate Appropriations Subcommittee on Labor, HHS, Education and Related Agencies (PDF)
  • FY2021 written testimony before U.S. House Appropriations Subcommittee on Labor, HHS, Education and Related Agencies (PDF)
  • FY 2020 written US Senate testimony
  • FY2020 Written Testimony before the US House Appropriations Committee on NIH Research (PDF)
  • FY2019 FSHSociety US Senate Testimony (PDF)
  • FY2019 Written Testimony before the US House Appropriations Committee on NIH Research (PDF)
  • FY 2018 written testimony for the record before the US House Subcommittee on Labor, HHS & Education regarding $26 million FY2018 appropriations to the National Institutes of Health (NIH) for research on facioscapulohumeral muscular dystrophy (FSHD)
  • FSH Society FY2017 Written Testimony before the US House Appropriations Committee on NIH Research, April 15, 2016
  • FSH Society FY2017 Written Testimony before the US Senate Appropriations Committee on NIH Research, April 15, 2016
  • FSH Society FY2016 Written Testimony before the US House Appropriations Committee on NIH Research, April 29, 2015 (PDF)
  • FSH Society FY2016 Written Testimony U.S. Senate Appropriations for NIH Research on FSHD March 31, 2015 (PDF)
  • FSH Society FY2015 Written Testimony U.S. Senate Appropriations for NIH Research on FSHD May 16, 2014 (PDF)
  • FSH Society FY2015 Written Testimony U.S. House Appropriations for NIH Research on FSHD March 28, 2014 (PDF)
  •  FSH Society FY2014 Written Testimony U.S. Senate Appropriations for NIH Research on FSHD May 6, 2013 (PDF)
  •  FSH Society FY2014 Written Testimony U.S. House Appropriations for NIH Research on FSHD March 15, 2013 (PDF)
  •  FSH Society FY2013 Written Testimony U.S. Senate Appropriations LHHSE for NIH Research on FSHD April 27, 2012 (PDF)
  •  FSH Society FY2013 Written Testimony U.S. House Appropriations for NIH Research on FSHD March 29, 2012 (PDF)
  •  FSH Society FY2012 Written Testimony U.S. House Appropriations for NIH Research on FSHD April 15, 2011 (PDF)
  •  FSH Society FY2012 Written Testimony U.S. Senate Appropriations for NIH Research on FSHD April 12, 2011 (PDF)
  •  FSH Society FY2011 Written Testimony U.S. House Appropriations for NIH Research on FSHD April 16, 2010 (PDF)
  •  FSH Society FY2011 Written Testimony U.S. Senate Appropriations for NIH Research on FSHD April 12, 2010 (PDF)
  •  FSH Society FY2010 Written Testimony U.S. Senate Appropriations for NIH Research on FSHD May 25, 2009 (PDF)
  •  FSH Society FY2010 Written Testimony U.S. House Appropriations for NIH Research on FSHD May 1, 2009 (PDF)
  •  FSH Society FY2009 Written Testimony U.S. Senate Appropriations for NIH Research on FSHD April 27, 2008 (PDF)
  •  FSH Society FY2009 Written Testimony U.S. House Appropriations for NIH Research on FSHD March 20, 2008 (PDF)  FSH Society FY2008 Written Testimony U.S. Senate Appropriations for NIH Research on FSHD March 30, 2007 (PDF)
  •  FSH Society FY2008 Written Testimony U.S. House Appropriations for NIH Research on FSHD March 27, 2007 (PDF)
  •  FSH Society FY2008 Oral Testimony (4 Minutes) U.S. House Appropriations for NIH Research on FSHD March 27, 2007 (PDF)

Sign up for Email Alerts

Stay up to date with the latest FSHD news and updates from FSHD Society.

CONNECT WITH US

Proud Member World FSHD Alliance (1)
Footer-Logo-min

General Mailing Address:

75 North Main Street, Suite 1073
Randolph, MA 02368 U.S.A.

Mail Donations to:

Department 960
PO Box 4106
Woburn, MA 01888-4106

(781) 301-6060

  • DONATE
  • Donate
  • Join Us
  • Inclusivity & Equity
  • Privacy Policy
  • Contact Us
  • Glossary Of Scientific Terms
Digital Marketing by